These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8587010)

  • 21. Effect of Indian Ayurvedic medicine Ashwagandha on measurement of serum digoxin and 11 commonly monitored drugs using immunoassays: study of protein binding and interaction with Digibind.
    Dasgupta A; Peterson A; Wells A; Actor JK
    Arch Pathol Lab Med; 2007 Aug; 131(8):1298-303. PubMed ID: 17683192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind).
    Dasgupta A; Reyes MA
    Am J Clin Pathol; 2005 Aug; 124(2):229-36. PubMed ID: 16040294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicity.
    Mauskopf JA; Wenger TL
    Am J Cardiol; 1991 Dec; 68(17):1709-14. PubMed ID: 1746476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
    Hickey AR; Wenger TL; Carpenter VP; Tilson HH; Hlatky MA; Furberg CD; Kirkpatrick CH; Strauss HC; Smith TW
    J Am Coll Cardiol; 1991 Mar; 17(3):590-8. PubMed ID: 1993775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant cardiac glycosides and digoxin Fab antibody.
    Cheung K; Urech R; Taylor L; Duffy P; Radford D
    J Paediatr Child Health; 1991 Oct; 27(5):312-3. PubMed ID: 1931226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe digoxin intoxication in a child treated by infusion of digoxin-specific Fab-antibody-fragments.
    Rossi R; Leititis JU; Hagel KJ; Smolarz A; Brandis M
    Eur J Pediatr; 1984 Jun; 142(2):138-40. PubMed ID: 6468431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay.
    Crossey MJ; Dasgupta A
    Ther Drug Monit; 1997 Apr; 19(2):185-90. PubMed ID: 9108648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of unbound digoxin in patients treated with anti-digoxin antigen-binding fragments: a model for the future?
    Valdes R; Jortani SA
    Clin Chem; 1998 Sep; 44(9):1883-5. PubMed ID: 9732971
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of digoxin immune Fab in patients with kidney failure.
    Ujhelyi MR; Robert S; Cummings DM; Colucci RD; Sailstad JM; Vlasses PH; Findlay JW; Zarowitz BJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):388-94. PubMed ID: 8222481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Severe poisoning with digitalis treated by the administration of anti-digoxin antibodies].
    Delgado Jiménez JF; Casillas Villamor A; Gómez Pajuelo C; Sáenz de la Calzada C
    Rev Clin Esp; 1991 Nov; 189(8):374-6. PubMed ID: 1784800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
    Smith TW; Lloyd BL; Spicer N; Haber E
    Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of digoxin antibodies on TDx digoxin assay.
    Argyle JC
    Clin Chem; 1986 Aug; 32(8):1616-7. PubMed ID: 3731484
    [No Abstract]   [Full Text] [Related]  

  • 34. Analytic performance of two automated nonpretreatment digoxin immunoassays.
    De BK; Booth DD; Magee PJ; Moore ML; Preuss TM; Rose TA; Roberts WL
    Ther Drug Monit; 1999 Feb; 21(1):123-8. PubMed ID: 10051065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oleander poisoning: treatment with digoxin-specific Fab antibody fragments.
    Shumaik GM; Wu AW; Ping AC
    Ann Emerg Med; 1988 Jul; 17(7):732-5. PubMed ID: 3382077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retreatment with digoxin immune Fab.
    Allen NM
    Clin Pharm; 1991 Nov; 10(11):823-4. PubMed ID: 1794217
    [No Abstract]   [Full Text] [Related]  

  • 37. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate control of life-threatening digoxin intoxication in a child by use of digoxin-specific antibody fragments (Fab).
    Husby P; Farstad M; Brock-Utne JG; Koller ME; Segadal L; Lund T; Ohm OJ
    Paediatr Anaesth; 2003 Jul; 13(6):541-9. PubMed ID: 12846714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation].
    Weller P; Peters U; Dickmanns HA; Hespe TH; Adam M; Allolio B; Smolarz A; Grabensee B
    Dtsch Med Wochenschr; 1983 Sep; 108(38):1437-40. PubMed ID: 6884234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.
    Thanh-Barthet CV; Urtizberea M; Sabouraud AE; Cano NJ; Scherrmann JM
    Pharm Res; 1993 May; 10(5):692-6. PubMed ID: 8321833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.